TuisSHTDY • OTCMKTS
add
Sinopharm Group ADR
Vorige sluiting
$12,39
Dagwisseling
$12,61 - $12,71
Jaarwisseling
$10,77 - $14,22
Markkapitalisasie
61,76 mjd HKD
Gemiddelde volume
127,82 k
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Inkomste | 145,44 mjd | -1,53% |
Bedryfskoste | 6,37 mjd | -6,94% |
Netto inkomste | 1,85 mjd | 16,88% |
Netto winsgrens | 1,27 | 18,69% |
Wins per aandeel | — | — |
EBITDA | 4,66 mjd | 3,57% |
Effektiewe belastingkoers | 24,66% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 38,77 mjd | — |
Totale bates | 418,38 mjd | — |
Totale aanspreeklikheid | 286,21 mjd | — |
Totale ekwiteit | 132,17 mjd | — |
Uitstaande aandele | 3,12 mjd | — |
Prys om te bespreek | 0,47 | — |
Opbrengs op bates | 2,46% | — |
Opbrengs op kapitaal | 4,71% | — |
Kontantvloei
Netto kontantverandering
| (CNY) | Sep. 2025info | J/J-verandering |
|---|---|---|
Netto inkomste | 1,85 mjd | 16,88% |
Kontant van bedrywe | -4,97 mjd | 26,15% |
Kontant van beleggings | 781,72 m | -19,99% |
Kontant van finansiering | -4,04 mjd | -162,10% |
Netto kontantverandering | -8,22 mjd | -12,59% |
Beskikbare kontantvloei | -1,34 mjd | — |
Meer oor
Sinopharm Group Co., Ltd. is a Chinese pharmaceutical company. The parent company of Sinopharm Group was Sinopharm Industrial Investment, a 51–49 joint venture of state-owned enterprise China National Pharmaceutical Group and civilian-run enterprise Fosun Pharmaceutical.
Its H shares were listed on the Hong Kong Stock Exchange in 2009, with its IPO price of HK$16 per share. Sinopharm Group's subsidiary Sinopharm CNMC and Sinopharm Accord served as the A share counterpart of the company. However, the A share of Sinopharm Group itself was unlisted.
Sinopharm Group was ranked 829th in 2016 Forbes Global 2000 list. Wikipedia
Gestig
2003
Webwerf
Werknemers
100 251
